# Neogen Corp: filings

NEOG · Nasdaq · CIK 711377 · [Healthcare](/sectors/healthcare.md) · fiscal year ends May 31

Pages: [Overview](/companies/neog.md) · [Financials](/companies/neog/financials.md) · [Filings](/companies/neog/filings.md) · [Insiders](/companies/neog/insiders.md)

## Reports and events: 280 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 844, 8-K 185, SC 13G/A 60, 10-Q 54, 3 28, 10-K 18, DEF 14A 18, 4/A 17, 425 14, CORRESP 14, SD 13, UPLOAD 13, SCHEDULE 13G/A 12, 11-K 11, SC 13G 10, SCHEDULE 13G 7, ARS 6, S-8 6, 8-K/A 5, S-4/A 5, 144 4, PRE 14A 4, PRER14A 4, DEFA14A 3, SEC STAFF LETTER 2, 3/A 1, 424B3 1, 5 1, DEFM14A 1, DEFR14A 1, EFFECT 1, NT 10-K 1, NT 10-Q 1, PREM14A 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 09:16 ET | [8-K/A](/filings/0001193125-26-431208.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-431208 |
| 2026-10-07 | 16:02 ET | [10-Q](/filings/0001193125-26-416954.md) | Quarterly report, period 2026-08-31 | 0001193125-26-416954 |
| 2026-10-07 | 08:55 ET | [8-K](/filings/0001193125-26-416247.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-416247 |
| 2026-10-06 | 16:05 ET | [8-K](/filings/0001193125-26-415544.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-415544 |
| 2026-08-21 | 14:02 ET | [DEF 14A](/filings/0001193125-26-360742.md) | Proxy statement, period 2026-08-21 | 0001193125-26-360742 |
| 2026-08-07 | 16:02 ET | [8-K](/filings/0001193125-26-340216.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-340216 |
| 2026-07-30 | 16:04 ET | [10-K](/filings/0001193125-26-326092.md) | Annual report, period 2026-05-31 | 0001193125-26-326092 |
| 2026-07-30 | 07:01 ET | [8-K](/filings/0001193125-26-324860.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-324860 |
| 2026-04-20 | 06:59 ET | [8-K](/filings/0001193125-26-162667.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-162667 |
| 2026-04-09 | 16:03 ET | [10-Q](/filings/0001193125-26-149599.md) | Quarterly report, period 2026-02-28 | 0001193125-26-149599 |
| 2026-04-09 | 07:01 ET | [8-K](/filings/0001193125-26-148851.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-148851 |
| 2026-03-30 | 08:19 ET | [8-K](/filings/0001193125-26-130470.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-130470 |
| 2026-01-08 | 16:07 ET | [10-Q](/filings/0001193125-26-007682.md) | Quarterly report, period 2025-11-30 | 0001193125-26-007682 |
| 2026-01-08 | 07:03 ET | [8-K](/filings/0001193125-26-006990.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-006990 |
| 2025-10-30 | 08:47 ET | [8-K](/filings/0001193125-25-257565.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-257565 |
| 2025-10-28 | 11:28 ET | [8-K/A](/filings/0001193125-25-252843.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-252843 |
| 2025-10-27 | 10:55 ET | [8-K/A](/filings/0001193125-25-250963.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-250963 |
| 2025-10-27 | 09:08 ET | [8-K](/filings/0001193125-25-250823.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-250823 |
| 2025-10-09 | 15:04 ET | [10-Q](/filings/0001193125-25-235720.md) | Quarterly report, period 2025-08-31 | 0001193125-25-235720 |
| 2025-10-09 | 07:02 ET | [8-K](/filings/0001193125-25-235081.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-235081 |
| 2025-09-15 | 16:09 ET | [8-K](/filings/0001193125-25-203554.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-203554 |
| 2025-09-12 | 09:32 ET | [DEF 14A](/filings/0000950170-25-114381.md) | Proxy statement, period 2025-09-12 | 0000950170-25-114381 |
| 2025-08-21 | 06:15 ET | [8-K](/filings/0000950170-25-110547.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-110547 |
| 2025-08-14 | 16:18 ET | [8-K](/filings/0000950170-25-108900.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-108900 |
| 2025-07-30 | 13:33 ET | [10-K](/filings/0000950170-25-100064.md) | Annual report, period 2025-05-31 | 0000950170-25-100064 |
| 2025-07-29 | 07:01 ET | [8-K](/filings/0000950170-25-099379.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-099379 |
| 2025-07-24 | 09:04 ET | [8-K](/filings/0000950170-25-098159.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-098159 |
| 2025-06-04 | 08:59 ET | [8-K](/filings/0000950170-25-081407.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-081407 |
| 2025-05-14 | 13:49 ET | [8-K](/filings/0000950170-25-071169.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-071169 |
| 2025-05-13 | 16:11 ET | [8-K](/filings/0000950170-25-070353.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-070353 |
| 2025-04-22 | 16:45 ET | [8-K](/filings/0000950170-25-056821.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-056821 |
| 2025-04-09 | 16:04 ET | [10-Q](/filings/0000950170-25-052497.md) | Quarterly report, period 2025-02-28 | 0000950170-25-052497 |
| 2025-04-09 | 07:06 ET | [8-K](/filings/0000950170-25-052304.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-052304 |
| 2025-04-09 | 07:00 ET | [8-K](/filings/0000950170-25-052302.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-052302 |
| 2025-04-07 | 12:36 ET | [8-K](/filings/0000950170-25-051441.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-051441 |
| 2025-01-15 | 15:53 ET | [10-Q](/filings/0000950170-25-005818.md) | Quarterly report, period 2024-11-30 | 0000950170-25-005818 |
| 2025-01-10 | 07:00 ET | [8-K](/filings/0000950170-25-003775.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-003775 |
| 2025-01-07 | 16:03 ET | [8-K](/filings/0000950170-25-002820.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-002820 |
| 2024-12-17 | 16:01 ET | [8-K/A](/filings/0000950170-24-137170.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-137170 |
| 2024-12-04 | 07:59 ET | [8-K](/filings/0000950170-24-133084.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-133084 |
| 2024-10-28 | 15:59 ET | [8-K](/filings/0000950170-24-117710.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-117710 |
| 2024-10-10 | 14:14 ET | [10-Q](/filings/0000950170-24-114022.md) | Quarterly report, period 2024-08-31 | 0000950170-24-114022 |
| 2024-10-10 | 07:00 ET | [8-K](/filings/0000950170-24-113951.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-113951 |
| 2024-10-10 | 06:52 ET | [8-K](/filings/0000950170-24-113950.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-113950 |
| 2024-10-01 | 08:54 ET | [8-K](/filings/0000950170-24-110564.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-110564 |
| 2024-09-13 | 09:26 ET | [DEF 14A](/filings/0000950170-24-106219.md) | Proxy statement, period 2024-10-24 | 0000950170-24-106219 |
| 2024-09-05 | 07:32 ET | [8-K](/filings/0000950170-24-103737.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-103737 |
| 2024-07-30 | 13:58 ET | [10-K](/filings/0000950170-24-087670.md) | Annual report, period 2024-05-31 | 0000950170-24-087670 |
| 2024-07-30 | 06:59 ET | [8-K](/filings/0000950170-24-087499.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-087499 |
| 2024-06-04 | 08:28 ET | [8-K](/filings/0000950170-24-068311.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-068311 |

Page 1 of 6. [Older](/companies/neog/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 15:36 ET. No prices; not investment advice.